Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University Hospital, Tours
Fondazione del Piemonte per l'Oncologia
Hôpital du Valais
Centre Oscar Lambret
Centre Oscar Lambret
Tang-Du Hospital
Guangzhou University of Traditional Chinese Medicine
University Hospital Heidelberg
Mayo Clinic
Zealand University Hospital
University Hospital Heidelberg
Institut Bergonié
Institute of Oncology Ljubljana
Brigham and Women's Hospital
Tau-MEDICAL Co., Ltd.
Peking Union Medical College Hospital
Abramson Cancer Center at Penn Medicine
Palo Alto Veterans Institute for Research
Abramson Cancer Center at Penn Medicine
The Netherlands Cancer Institute
University of Cincinnati
Aarhus University Hospital
Jonsson Comprehensive Cancer Center
University of Nebraska
University of Texas Southwestern Medical Center
Duke University
VA Office of Research and Development
Ohio State University Comprehensive Cancer Center
Fudan University
Dana-Farber Cancer Institute
Hacettepe University
Wake Forest University Health Sciences
H. Lee Moffitt Cancer Center and Research Institute
University of Maryland, Baltimore
Columbia University
Varian, a Siemens Healthineers Company
University of Utah
Chung Shan Medical University
Université Catholique de Louvain
Rutgers, The State University of New Jersey
The First Affiliated Hospital of Guangzhou Medical University
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Thomas Jefferson University
Boehringer Ingelheim
Nantes University Hospital
Ezisurg Medical Co. Ltd.
First Affiliated Hospital of Ningbo University
Guangzhou University of Traditional Chinese Medicine
University of Washington